Friday, February 10, 2012

FDA Approves Crestor for Wider Use

(Reuters) UPDATED 2010-02-08
The U.S. Food and Drug Administration has approved AstraZeneca's cholesterol-lowering drug Crestor (rosuvastatin) for older adults who have healthy cholesterol levels but other heart risks. The approval was based on the "Jupiter" study, an AstraZeneca-funded clinical trial that involved 18,000 people. In this study, researchers found that Crestor could help prevent stroke, heart attack, and other cardiac problems in patients who have normal cholesterol levels but high C-reactive protein levels and at least one other heart risk factor. C-reactive protein is a marker of inflammation that has been linked to an increased risk of heart disease.
  Read full story >
See all Cholesterol News

People who read this also read...

  • Crestor Danger
  • Crestor Warning
  • Crestor (rosuvastatin) Dosage
  • Function Of Crestor
  • Can Crestor Cause Sciatica?
  • The Structure Of Crestor